Saint Bella — Investor Fact Book

Saint Bella Group 圣贝拉

FY2025 results (announced 2026-03-30) + filings through mid-2026 · generated 2026-08-15

Filed and verified facts only. Safe to share. Numbers trace to the company’s HKEX filings.

RMB 1,045.9M
FY2025 revenue
+31.0% YoY
F-104Filed
RMB 124.6M
Adjusted net profit
+194.9% · margin 11.9%
F-107Filed
36.0%
Gross margin
+2.1pp (was 33.9%)
F-105Filed
140 + 8
Centers
mainland + overseas · 41 cities
F-174Filed
No.1
Market rank
Asia & China, 2024 · 1.2% share
F-228Filed
RMB 267k
Flagship ASP
Saint Bella brand · +11.6%, 8 yrs up
F-056Filed
100,000+
Families served
over 8 years
F-178Filed
RMB 549.6M
Cash position
up from 66.0M (2024)
F-116Filed
FiledFrom HKEX filings (prospectus, results, announcements) — the primary record.
AnalystFrom a third-party analyst report; ranks below the company's own filings.
PressFrom the company website or press coverage.

Financials

P&L, four-year track, segments, margins

Revenue, RMB M · CAGR 36.7% (2023–25) · F-118
4722022560202379920241,0462025
Adjusted net profit, RMB M · +195% in 2025 · margin 5.3%→11.9% · F-107/F-125
2120234220241252025
FY2025 revenue by segment · F-110 / F-111 / F-112
Postpartum centersRMB 899.3M · 86%Home care81.9M · +36.7%Health food (GHT)64.7M · +26.3%
FY2025 revenue
RMB 1,045.859M, +31.0% (FY2024: 798.666M)
F-104FiledFY2025
FY2025 gross profit & margin
GP RMB 376.226M (+39.1%); gross margin 36.0% (was 33.9%)
F-105FiledFY2025
FY2025 statutory net profit
RMB 411.180M — includes a one-off, non-cash +318.189M fair-value gain (preferred shares converting at IPO). Durable operating figure = adjusted NP 124.6M (F-107).
F-106FiledFY2025CAVEAT
FY2025 adjusted net profit & margin
RMB 124.601M, +194.9% (FY2024: 42.256M); margin 11.9% (was 5.3%)
F-107FiledFY2025
FY2025 adjusted EBITDA
RMB 174.346M (FY2024: 72.474M)
F-108FiledFY2025
FY2025 EPS
Basic RMB 1.27; diluted RMB 0.27 (FY2024: LPS 102.12)
F-109FiledFY2025
Four-year revenue track
2022: 471.5M → 2023: 559.9M → 2024: 798.7M → 2025: 1,045.9M (2023→2025 CAGR 36.7%)
F-118FiledFY2022–25
Segment — postpartum centers
RMB 899.3M, +30.8% (~86% of revenue)
F-110FiledFY2025
Segment — home care (PrimeCare)
RMB 81.9M, +36.7%; gross margin 37.2%
F-111FiledFY2025
Segment — health food (GHT)
RMB 64.7M, +26.3%; gross margin 72.8% (+11.3pp); No.1 Tmall nutrition 2022–25
F-112FiledFY2025
Revenue by geography
Mainland RMB 1,021.6M; overseas 24.3M (~2.3%); services 968.5M / products 77.3M
F-113FiledFY2025
Expense ratios (adjusted)
Marketing 10.5% (−1.4pp); admin 14.6% (−1.4pp)
F-114FiledFY2025
Cash position
Cash RMB 549.6M (2024: 66.0M) + restricted/deposits 158.3M
F-116Filed2025-12-31
Dividend
None paid or declared for FY2025
F-115FiledFY2025
Balance-sheet turnaround
Total equity +998.6M end-2025 (owners +983.9M) vs attributable −1,460.4M end-2024 — pre-IPO preferred-share liabilities cleared at listing
F-119Filed2025-12-31
H1 2025 results
Revenue 449.5M (+25.6%); GM 37.6%; adjusted NP 38.8M (+126.1%), margin 8.6%; combined revenue incl. managed 522.5M
F-120FiledH1 2025
Gross margin by segment 2022/23/24
Total 29.9/36.5/33.9%; centers 28.7/34.1/31.8%; food 43.7/63.3/61.5%
F-124Filed2024
Operating cash flow
Positive every year: +24.1 / +56.7 / +49.1M (2022/23/24) — cash-generative even through the statutory-loss years
F-126Filed2024

Unit economics

ASP, pricing, conversion, payback

ASP by brand FY2025
Group RMB 156,059 (+5.0%); Saint Bella 266,796 (+11.6%); Baby Bella 108,375 (+12.6%); Bella Isla 171,896 (+2.8%)
F-176FiledFY2025
Flagship pricing power (chairman)
Saint Bella brand ASP RMB 267,000, +11.6%; double-digit ASP growth 8 consecutive years; never cut prices
F-056FiledFY2025
Pricing 2024 (prospectus)
Avg revenue/customer: Saint Bella 239,155; Bella Isla 167,197; Baby Bella 96,246; per room-night RMB 7,015; 28-day packages from 138,800 / 108,800 / 68,800
F-182Filed2024
Secondary-sales conversion & diversified mix
95.5% comprehensive secondary-sales conversion; diversified offerings 29.5% of revenue
F-177FiledFY2025
Hotel asset-light model
Centers inside upscale hotels; 405/459/867 rooms reserved 2022/23/24; new centers cash-flow positive within ~3 months; minimal renovation capex
F-183Filed2024
Center revenue by brand 2024
Saint Bella care 269.6M + recovery 54.8M; Baby Bella care 222.4M + recovery 32.4M; Bella Isla 43.9M + 5.4M
F-057Filed2024
Home care metrics
~9,500 licensed baby-sitters (+36.0%); avg contract 122.8 days; 823 customers (+20.9%); renewal ~56.7%
F-179FiledFY2025
Staffing & volumes (prospectus)
693 qualified nursing specialists; 4,439 postpartum packages sold 2024 (~38% via referrals/own channels)
F-184Filed2024

Network & expansion

Store counts, overseas, M&A

Mainland center count
140 mainland centers as of 2025-12-31 (net +63 from 77)
F-174Filed2025-12-31
Global network scale
140 stores across 41 cities worldwide; No.1 in postpartum care in Asia by scale; outlook 'nearly 150 stores'
F-175Filed2026-03-30
Center network by year
2022: 36 → 2023: 43 → 2024: 77 → Jun 2025: 96 (62 self-op / 34 managed)
F-180Filed2025-06-10
Footprint + 2026 plan
140 stores / 41 cities at AR date; 2026 plan: 15 new stores in 10 cities; countries: China (incl. HK), Singapore, US, Thailand
F-185Filed2026-04-29
Footprint at prospectus
27 mainland cities + HK + Singapore + Greater LA; ~30 cities, 3 countries
F-181Filed2025-06-10
Overseas footprint FY2025
4 overseas cities, 8 overseas centers in 2025; overseas GMV +280.0% YoY (off a ~2.3%-of-revenue base); markets: Singapore, North America, Australia
F-294FiledFY2025
Five-city expansion (signed)
Eastern US, UK, France, Thailand, Australia; strategic agreements SIGNED with partners in NY, London, Paris, Bangkok
F-296Filed2026-02-11
Wuhan Freya acquisition
30–40% minority stakes in 4 Wuhan Freya (弗蕾亚) companies for ~RMB 22.4M; board control of 3 (consolidated); option to 60–80%. Freya: est. 2013, 3 shops, 160+ rooms, ASP ~RMB 50k, ~10,000 HNW families
F-297Filed2026-06-22
US debut
Jul 15 2025: Waldorf Astoria Monarch Beach (CA) + Baccarat Hotel New York
F-298Press2025-07-15
FY2026 outlook
Organic + M&A; 'only postpartum brand globally with total scale >RMB 1B'; overseas into Europe + Middle East; Dr. Bella across nearly 150 stores; no quantitative guidance
F-295Filed2026-03-30

Brands & lifecycle

Portfolio, tiers, the membership pillar

Brand portfolio & launch years
Saint Bella 2017; Baby Bella 2019; Bella Isla 2024; STB (recovery) 2022; PrimeCare 予家 2018; GHT 广禾堂 acquired Oct 2021; S-bra acquired May 2022
F-058Filed2025-06-18
Existing membership program
圣贝拉会员权益中心 with tiers 悦己 (Self-care) / 金卡 (Gold) / 铂金 (Platinum): concierge benefits, members-only events, points mall, UCCA art visits + Kids study tours, psychology counseling, IPHI infant sleep guidance, 24H 1-on-1 in-home nurse
F-060Press2026-07-22
GHT 广禾堂 category position
No.1 in Tmall postpartum-nutrition category 2022–2025; food gross margin 72.8%; ~70% e-commerce share (founded 2003 Shanghai)
F-112FiledFY2025
Average customer spend
>RMB 230k avg spend (2024); nightly ~6,740–7,015 — above every benchmark's annual membership fee
F-234Press2024
Awards
2023 Robb Report Best of the Best (Luxury Family Wellness); Marie Claire Top 100; Forbes China maternal & child health Top 10
F-061Press2023

Market & share

TAM, penetration, competitive rank

Postpartum-CENTER penetration · 9–10x headroom · F-231
6.0%China (2024)1.3%China (2019)>60%S. Korea / Taiwan
Market position (F&S)
Largest postpartum care+recovery group in Asia AND China by 2024 center revenue (RMB 628M, 1.2% share; No.2 = 418M); fastest-growing scaled group (26.4% CAGR); No.1 ultra-premium (374M vs 89M)
F-228Filed2024
Competitive ranking (F&S)
No.1 by 2024 center revenue: Group 628M (1.2%) vs A 418M (0.8%), E-Korea 403M, B 366M, F 279M
F-233Filed2024-12-31
Market size (F&S)
Postpartum care+recovery: RMB 38.6B (2019) → 67.5B (2024), CAGR 11.8%; → 79.3B (2025E) → 200.8B (2030E), CAGR 20.4%
F-230Filed2025-06-18
Penetration & headroom (F&S)
Postpartum care services 7.5% (2019) → 17.0% (2024); centers 1.3% → 6.0%; South Korea / Taiwan >60%
F-231Filed2025-06-18
Market context (FY2025 results)
China home care industry RMB 805.3B (2025E) → >928.0B (2026E); postpartum+childcare+nutrition 298.4B in 2025 (+17.5%)
F-229FiledFY2025
Adjacent markets (F&S)
Family care industry 711.3B (2024) → 1,443.8B (2030E); home childcare 35.8B → 105.2B (2030E); China births 14.7M (2019) → 9.5M (2024)
F-232Filed2025-06-18
Natal-policy tailwind
National childcare subsidy RMB 3,600/child/yr for under-3s (from 2025-01-01; >24M recipients); under-3 tax deduction raised to RMB 2,000/mo
F-401Analyst2025

AI & technology

Dr. Bella, Yunji, robotics fund

AI business 2025 (filed)
Launched Dr. Bella (self-developed vertical AI agent); strategic investment in WITH1000 (>10M sets clinical data from 400+ institutions); Yunji partnership; embodied-intelligence fund
F-346FiledFY2025
Yunji robotics framework
NON-BINDING cooperation framework with Beijing Yunji Technology (02670.HK): AI + robotics in home care; link ~150 scenarios + >1M clinical data sets; JV 'to be explored'; 'may or may not proceed'
F-347Filed2026-01-19
Robotics fund
Investor in a RMB 1B fund (Shanghai Dunhong Capital, >10B AUM; prior: Unitree, Lingban), targeting embodied robots; funded from operating income
F-348Filed2026-03-24
Dr. Bella product
Dr. Bella = AI health agent for women across pregnancy, birth and parenting
F-063Press2026-07-22

Ownership & governance

Shareholders, cornerstones, buyback

Listing
Dealings commenced 2025-06-26, HKEX Main Board, stock code 2508
F-017Filed2025-06-26
Global offering
95,420,000 offer shares at HK$6.58 fixed price; board lot 500
F-018Filed2025-06-18
Final offer outcome
Offer Size Adjustment Option fully exercised: 109,733,000 shares at HK$6.58; net proceeds HK$629.95M; HK tranche 193.00x, intl 15.59x subscribed
F-019Filed2025-06-25
Market cap at offer price
HK$3,917.9M
F-020Filed2025-06-18
Use of proceeds
~29% network expansion; ~37% new services/products (incl. elderly care, retail, recovery); ~6% training; ~18% R&D/AI/data; ~9% working capital
F-023Filed2025-06-18
Substantial shareholders post-IPO
Danny Xiang 35.68%; Minee Lin 9.98%; Tencent Mobility 9.75%
F-377Filed2025-06-18
Pre-IPO investor register
Tencent 11.61% (RMB 150M Series C), Gaorong 8.26%, Ningbo Tangzhu 6.61%, SHK 2.98%, China Life 1.96%, Mirae 1.75%, C Capital (Adrian Cheng) 1.69%, Swire 0.68%; total pre-IPO raised >RMB 300M
F-378Filed2025-06-18
Cornerstone investors
US$41.46M / 49.443M shares (51.82% of base): GIMM $6.37M, ChinaAMC(HK) $4.0M, JKKB $13.08M, Carl Wu $1.0M, SS Morgan $6.0M, Minwise $4.0M, Wang Qianqing $7.0M
F-379Filed2025-06-18
Ownership & strategic holders
Danny Xiang + vehicles ~35.7% controlling; strategic holders incl. Tencent, Swire Properties, SHK Strategic, Mirae Asset
F-373Filed2025-06-18
Founder
Danny Xiang (向华), 38 — founder / Chairman / CEO; Oxford engineering; ex-UBS Asia M&A
F-375Filed2025-06-18
Co-founder
Minee Lin (林宛颐), 37 — co-founder & COO since Jul 2017
F-376Filed2025-06-18
Board & INEDs
Liang Jun (Tencent, non-exec); INEDs Wu Shuqing, Rainer Bürkle (ex-Marriott Greater China luxury VP), Shen Guanxian (ex-GS/Citi/CICC)
F-381Press2026-07-22
L Catterton cooperation
Strategic cooperation announced via HKEX voluntary announcement (2026-03-18): technology & consumer-insight support, joint investment incubation + acquisitions toward a multi-brand global home-care group
F-374Filed2026-03-18
L Catterton scope
L Catterton (~$40B AUM, 300+ brands): international expansion, HNW consumer insights, membership-system optimization, M&A pipeline
F-382Press2026-05-14
Share buyback
Up to HK$100M on-market buyback, price cap HK$6.85, 2026-06-30 → 2028-06-29; rationale: price below intrinsic value
F-015Filed2026-06-30
Share price vs IPO
IPO HK$6.58 (Jun 2025); ~HK$5.45 (Feb 2026); ~HK$3.39 (Jul 2026) ≈ −48% vs IPO; award trustee bought at avg HK$3.81
F-129Press2026-07-10LIVE
IPO proceeds deployment
Net HK$709.1M raised (incl. over-allotment); only HK$113.1M (~16%) deployed in 2025 — dry powder for expansion + M&A
F-117Filed2025-12-31
Insider buying & lock-up
Controlling shareholder increased his stake with a voluntary lock-up (2026-01-09); 2025 incentive plan authorises repurchase up to 2% of shares via Futu Trust
F-016Filed2026-01-09
Company rename
SAINT BELLA Inc. → SAINT BELLA GROUP LIMITED (聖貝拉集團有限公司); EGM 2026-02-05
F-014Filed2026-03

Membership benchmarks

RH, Soho House, Quintessentially, Amex

Restoration Hardware (RH) membership
Members drove ~98% of core sales; ~265,000 members (FY2024); fee income immaterial vs ~$3.2B revenue
F-391Press2025-02-01
RH fee model
Grey Card $100 → $200/yr; member discount 25% → 30%; converts discounting into a paid club, self-selects high-intent customers
F-392Press2025-06-11
Amex Centurion
Invite-only; $10,000 initiation + $5,000/yr; pure status-gate pricing
F-393Press2026
Quintessentially
Tiers ~£2,000 (entry) → £25,000+ (Elite); travel / access / education advisory — closest HNW family-concierge model
F-394Press2026
Soho House
£3,800/yr Every House; 270k+ members, 48 houses; taken private $2.7B EV (Aug 2025), never profitable as a listed co.
F-395Press2025-08-18

Risk factors

Key risk factors from the prospectus

Top prospectus risk factors
Competition; growth-execution; service quality; negative publicity; marketing efficiency; dependence on hotel relationships (generally no long-term agreements); new/acquired centers underperforming; incidents/liability; regulatory compliance
F-022Filed2025-06-18

Full fact registry

Filed and verified facts only. Search filters this table too; the chips filter by source.

IDClaimValueAs-ofSourceSection
F-063Dr. Bella productDr. Bella = AI health agent for women across pregnancy, birth and parenting2026-07-22Pressai-tech
F-346AI business 2025 (filed)Launched Dr. Bella (self-developed vertical AI agent); strategic investment in WITH1000 (>10M sets clinical data from 400+ institutions); Yunji partnership; embodied-intelligence fundFY2025Filedai-tech
F-347Yunji robotics frameworkNON-BINDING cooperation framework with Beijing Yunji Technology (02670.HK): AI + robotics in home care; link ~150 scenarios + >1M clinical data sets; JV 'to be explored'; 'may or may not proceed'2026-01-19Filedai-tech
F-348Robotics fundInvestor in a RMB 1B fund (Shanghai Dunhong Capital, >10B AUM; prior: Unitree, Lingban), targeting embodied robots; funded from operating income2026-03-24Filedai-tech
F-391Restoration Hardware (RH) membershipMembers drove ~98% of core sales; ~265,000 members (FY2024); fee income immaterial vs ~$3.2B revenue2025-02-01Pressbenchmarks
F-392RH fee modelGrey Card $100 → $200/yr; member discount 25% → 30%; converts discounting into a paid club, self-selects high-intent customers2025-06-11Pressbenchmarks
F-393Amex CenturionInvite-only; $10,000 initiation + $5,000/yr; pure status-gate pricing2026Pressbenchmarks
F-394QuintessentiallyTiers ~£2,000 (entry) → £25,000+ (Elite); travel / access / education advisory — closest HNW family-concierge model2026Pressbenchmarks
F-395Soho House£3,800/yr Every House; 270k+ members, 48 houses; taken private $2.7B EV (Aug 2025), never profitable as a listed co.2025-08-18Pressbenchmarks
F-058Brand portfolio & launch yearsSaint Bella 2017; Baby Bella 2019; Bella Isla 2024; STB (recovery) 2022; PrimeCare 予家 2018; GHT 广禾堂 acquired Oct 2021; S-bra acquired May 20222025-06-18Filedbrands
F-060Existing membership program圣贝拉会员权益中心 with tiers 悦己 (Self-care) / 金卡 (Gold) / 铂金 (Platinum): concierge benefits, members-only events, points mall, UCCA art visits + Kids study tours, psychology counseling, IPHI infant sleep guidance, 24H 1-on-1 in-home nurse2026-07-22Pressbrands
F-061Awards2023 Robb Report Best of the Best (Luxury Family Wellness); Marie Claire Top 100; Forbes China maternal & child health Top 102023Pressbrands
F-112GHT 广禾堂 category positionNo.1 in Tmall postpartum-nutrition category 2022–2025; food gross margin 72.8%; ~70% e-commerce share (founded 2003 Shanghai)FY2025Filedbrands
F-234Average customer spend>RMB 230k avg spend (2024); nightly ~6,740–7,015 — above every benchmark's annual membership fee2024Pressbrands
F-104FY2025 revenueRMB 1,045.859M, +31.0% (FY2024: 798.666M)FY2025Filedfinancials
F-105FY2025 gross profit & marginGP RMB 376.226M (+39.1%); gross margin 36.0% (was 33.9%)FY2025Filedfinancials
F-106FY2025 statutory net profitRMB 411.180M — includes a one-off, non-cash +318.189M fair-value gain (preferred shares converting at IPO). Durable operating figure = adjusted NP 124.6M (F-107).FY2025Filedfinancials
F-107FY2025 adjusted net profit & marginRMB 124.601M, +194.9% (FY2024: 42.256M); margin 11.9% (was 5.3%)FY2025Filedfinancials
F-108FY2025 adjusted EBITDARMB 174.346M (FY2024: 72.474M)FY2025Filedfinancials
F-109FY2025 EPSBasic RMB 1.27; diluted RMB 0.27 (FY2024: LPS 102.12)FY2025Filedfinancials
F-110Segment — postpartum centersRMB 899.3M, +30.8% (~86% of revenue)FY2025Filedfinancials
F-111Segment — home care (PrimeCare)RMB 81.9M, +36.7%; gross margin 37.2%FY2025Filedfinancials
F-112Segment — health food (GHT)RMB 64.7M, +26.3%; gross margin 72.8% (+11.3pp); No.1 Tmall nutrition 2022–25FY2025Filedfinancials
F-113Revenue by geographyMainland RMB 1,021.6M; overseas 24.3M (~2.3%); services 968.5M / products 77.3MFY2025Filedfinancials
F-114Expense ratios (adjusted)Marketing 10.5% (−1.4pp); admin 14.6% (−1.4pp)FY2025Filedfinancials
F-115DividendNone paid or declared for FY2025FY2025Filedfinancials
F-116Cash positionCash RMB 549.6M (2024: 66.0M) + restricted/deposits 158.3M2025-12-31Filedfinancials
F-118Four-year revenue track2022: 471.5M → 2023: 559.9M → 2024: 798.7M → 2025: 1,045.9M (2023→2025 CAGR 36.7%)FY2022–25Filedfinancials
F-119Balance-sheet turnaroundTotal equity +998.6M end-2025 (owners +983.9M) vs attributable −1,460.4M end-2024 — pre-IPO preferred-share liabilities cleared at listing2025-12-31Filedfinancials
F-120H1 2025 resultsRevenue 449.5M (+25.6%); GM 37.6%; adjusted NP 38.8M (+126.1%), margin 8.6%; combined revenue incl. managed 522.5MH1 2025Filedfinancials
F-124Gross margin by segment 2022/23/24Total 29.9/36.5/33.9%; centers 28.7/34.1/31.8%; food 43.7/63.3/61.5%2024Filedfinancials
F-126Operating cash flowPositive every year: +24.1 / +56.7 / +49.1M (2022/23/24) — cash-generative even through the statutory-loss years2024Filedfinancials
F-228Market position (F&S)Largest postpartum care+recovery group in Asia AND China by 2024 center revenue (RMB 628M, 1.2% share; No.2 = 418M); fastest-growing scaled group (26.4% CAGR); No.1 ultra-premium (374M vs 89M)2024Filedmarket
F-229Market context (FY2025 results)China home care industry RMB 805.3B (2025E) → >928.0B (2026E); postpartum+childcare+nutrition 298.4B in 2025 (+17.5%)FY2025Filedmarket
F-230Market size (F&S)Postpartum care+recovery: RMB 38.6B (2019) → 67.5B (2024), CAGR 11.8%; → 79.3B (2025E) → 200.8B (2030E), CAGR 20.4%2025-06-18Filedmarket
F-231Penetration & headroom (F&S)Postpartum care services 7.5% (2019) → 17.0% (2024); centers 1.3% → 6.0%; South Korea / Taiwan >60%2025-06-18Filedmarket
F-232Adjacent markets (F&S)Family care industry 711.3B (2024) → 1,443.8B (2030E); home childcare 35.8B → 105.2B (2030E); China births 14.7M (2019) → 9.5M (2024)2025-06-18Filedmarket
F-233Competitive ranking (F&S)No.1 by 2024 center revenue: Group 628M (1.2%) vs A 418M (0.8%), E-Korea 403M, B 366M, F 279M2024-12-31Filedmarket
F-401Natal-policy tailwindNational childcare subsidy RMB 3,600/child/yr for under-3s (from 2025-01-01; >24M recipients); under-3 tax deduction raised to RMB 2,000/mo2025Analystmarket
F-174Mainland center count140 mainland centers as of 2025-12-31 (net +63 from 77)2025-12-31Filednetwork
F-175Global network scale140 stores across 41 cities worldwide; No.1 in postpartum care in Asia by scale; outlook 'nearly 150 stores'2026-03-30Filednetwork
F-180Center network by year2022: 36 → 2023: 43 → 2024: 77 → Jun 2025: 96 (62 self-op / 34 managed)2025-06-10Filednetwork
F-181Footprint at prospectus27 mainland cities + HK + Singapore + Greater LA; ~30 cities, 3 countries2025-06-10Filednetwork
F-185Footprint + 2026 plan140 stores / 41 cities at AR date; 2026 plan: 15 new stores in 10 cities; countries: China (incl. HK), Singapore, US, Thailand2026-04-29Filednetwork
F-294Overseas footprint FY20254 overseas cities, 8 overseas centers in 2025; overseas GMV +280.0% YoY (off a ~2.3%-of-revenue base); markets: Singapore, North America, AustraliaFY2025Filednetwork
F-295FY2026 outlookOrganic + M&A; 'only postpartum brand globally with total scale >RMB 1B'; overseas into Europe + Middle East; Dr. Bella across nearly 150 stores; no quantitative guidance2026-03-30Filednetwork
F-296Five-city expansion (signed)Eastern US, UK, France, Thailand, Australia; strategic agreements SIGNED with partners in NY, London, Paris, Bangkok2026-02-11Filednetwork
F-297Wuhan Freya acquisition30–40% minority stakes in 4 Wuhan Freya (弗蕾亚) companies for ~RMB 22.4M; board control of 3 (consolidated); option to 60–80%. Freya: est. 2013, 3 shops, 160+ rooms, ASP ~RMB 50k, ~10,000 HNW families2026-06-22Filednetwork
F-298US debutJul 15 2025: Waldorf Astoria Monarch Beach (CA) + Baccarat Hotel New York2025-07-15Pressnetwork
F-014Company renameSAINT BELLA Inc. → SAINT BELLA GROUP LIMITED (聖貝拉集團有限公司); EGM 2026-02-052026-03Filedownership
F-015Share buybackUp to HK$100M on-market buyback, price cap HK$6.85, 2026-06-30 → 2028-06-29; rationale: price below intrinsic value2026-06-30Filedownership
F-016Insider buying & lock-upControlling shareholder increased his stake with a voluntary lock-up (2026-01-09); 2025 incentive plan authorises repurchase up to 2% of shares via Futu Trust2026-01-09Filedownership
F-017ListingDealings commenced 2025-06-26, HKEX Main Board, stock code 25082025-06-26Filedownership
F-018Global offering95,420,000 offer shares at HK$6.58 fixed price; board lot 5002025-06-18Filedownership
F-019Final offer outcomeOffer Size Adjustment Option fully exercised: 109,733,000 shares at HK$6.58; net proceeds HK$629.95M; HK tranche 193.00x, intl 15.59x subscribed2025-06-25Filedownership
F-020Market cap at offer priceHK$3,917.9M2025-06-18Filedownership
F-023Use of proceeds~29% network expansion; ~37% new services/products (incl. elderly care, retail, recovery); ~6% training; ~18% R&D/AI/data; ~9% working capital2025-06-18Filedownership
F-117IPO proceeds deploymentNet HK$709.1M raised (incl. over-allotment); only HK$113.1M (~16%) deployed in 2025 — dry powder for expansion + M&A2025-12-31Filedownership
F-129Share price vs IPOIPO HK$6.58 (Jun 2025); ~HK$5.45 (Feb 2026); ~HK$3.39 (Jul 2026) ≈ −48% vs IPO; award trustee bought at avg HK$3.812026-07-10Pressownership
F-373Ownership & strategic holdersDanny Xiang + vehicles ~35.7% controlling; strategic holders incl. Tencent, Swire Properties, SHK Strategic, Mirae Asset2025-06-18Filedownership
F-374L Catterton cooperationStrategic cooperation announced via HKEX voluntary announcement (2026-03-18): technology & consumer-insight support, joint investment incubation + acquisitions toward a multi-brand global home-care group2026-03-18Filedownership
F-375FounderDanny Xiang (向华), 38 — founder / Chairman / CEO; Oxford engineering; ex-UBS Asia M&A2025-06-18Filedownership
F-376Co-founderMinee Lin (林宛颐), 37 — co-founder & COO since Jul 20172025-06-18Filedownership
F-377Substantial shareholders post-IPODanny Xiang 35.68%; Minee Lin 9.98%; Tencent Mobility 9.75%2025-06-18Filedownership
F-378Pre-IPO investor registerTencent 11.61% (RMB 150M Series C), Gaorong 8.26%, Ningbo Tangzhu 6.61%, SHK 2.98%, China Life 1.96%, Mirae 1.75%, C Capital (Adrian Cheng) 1.69%, Swire 0.68%; total pre-IPO raised >RMB 300M2025-06-18Filedownership
F-379Cornerstone investorsUS$41.46M / 49.443M shares (51.82% of base): GIMM $6.37M, ChinaAMC(HK) $4.0M, JKKB $13.08M, Carl Wu $1.0M, SS Morgan $6.0M, Minwise $4.0M, Wang Qianqing $7.0M2025-06-18Filedownership
F-381Board & INEDsLiang Jun (Tencent, non-exec); INEDs Wu Shuqing, Rainer Bürkle (ex-Marriott Greater China luxury VP), Shen Guanxian (ex-GS/Citi/CICC)2026-07-22Pressownership
F-382L Catterton scopeL Catterton (~$40B AUM, 300+ brands): international expansion, HNW consumer insights, membership-system optimization, M&A pipeline2026-05-14Pressownership
F-022Top prospectus risk factorsCompetition; growth-execution; service quality; negative publicity; marketing efficiency; dependence on hotel relationships (generally no long-term agreements); new/acquired centers underperforming; incidents/liability; regulatory compliance2025-06-18Filedrisks
F-056Flagship pricing power (chairman)Saint Bella brand ASP RMB 267,000, +11.6%; double-digit ASP growth 8 consecutive years; never cut pricesFY2025Filedunit-econ
F-057Center revenue by brand 2024Saint Bella care 269.6M + recovery 54.8M; Baby Bella care 222.4M + recovery 32.4M; Bella Isla 43.9M + 5.4M2024Filedunit-econ
F-176ASP by brand FY2025Group RMB 156,059 (+5.0%); Saint Bella 266,796 (+11.6%); Baby Bella 108,375 (+12.6%); Bella Isla 171,896 (+2.8%)FY2025Filedunit-econ
F-177Secondary-sales conversion & diversified mix95.5% comprehensive secondary-sales conversion; diversified offerings 29.5% of revenueFY2025Filedunit-econ
F-179Home care metrics~9,500 licensed baby-sitters (+36.0%); avg contract 122.8 days; 823 customers (+20.9%); renewal ~56.7%FY2025Filedunit-econ
F-182Pricing 2024 (prospectus)Avg revenue/customer: Saint Bella 239,155; Bella Isla 167,197; Baby Bella 96,246; per room-night RMB 7,015; 28-day packages from 138,800 / 108,800 / 68,8002024Filedunit-econ
F-183Hotel asset-light modelCenters inside upscale hotels; 405/459/867 rooms reserved 2022/23/24; new centers cash-flow positive within ~3 months; minimal renovation capex2024Filedunit-econ
F-184Staffing & volumes (prospectus)693 qualified nursing specialists; 4,439 postpartum packages sold 2024 (~38% via referrals/own channels)2024Filedunit-econ